Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021

Nesrin Ghanem-Zoubi1Comments to Author , Yafit Atiya-Nasagi1, Evgeniy Stoyanov, Moran Szwarcwort, Basel Darawsha, Mical Paul, and Eilat Shinar
Author affiliations: Rambam Health Care Campus, Haifa, Israel (N. Ghanem-Zoubi, M. Szwarcwort, M. Paul); The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa (N. Ghanem-Zoubi, B. Darawsha, M. Paul); Israel Institute for Biological Research, Ness-Ziona, Israel (Y. Atiya-Nasagi); Magen David Adom National Blood Services, Ramat Gan, Israel (E. Stoyanov, E. Shinar)

Main Article

Table 2

Crude prevalence of anti-Coxiella burnetti IgG in cohort groups in cross-sectional study of Q fever seroprevalence among blood donors, Israel, 2021

Parameter No. participants No. seropositive (%)
Overall
 1,473
 188 (12.7)
Sex
M 859 128 (14.9)
F
 614
 60 (9.8)
Age group, y
18–30 y 550 50 (9.0)
31–50 y 502 85 (16.9)
>50 y
 299
 52 (17.4)
Geographic factors
Born in Israel 1,205 153 (12.7)
Living in Jewish locality 1,310 167 (12.7)
Living in Arab locality 157 21 (13.4)
Rural 372 38 (10.2)
Urban
 1,095
 150 (13.7)
Socioeconomic status of residence localities
Low 328 39 (11.9)
Middle 714 94 (13.2)
High 416 54 (13.0)

Main Article

1These authors contributed equally to this article.

Page created: March 07, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external